Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Col-De Beys

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Thrombosis and Haemostasis|August 28, 1981
Effects of suloctidil on platelet survival time following cardiac valve replacementC Col-de Beys, A Ferrant, M Moriau
Thrombosis and Haemostasis|February 26, 1982
Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.)M Moriau, C Col-De Beys, E Pardonge, et al.
Acta Belgica. Medica Physica : Organe Officiel De La Societe Royale Belge De Medecine Physique Et De Rehabilitation|October 1, 1990
Fibrinolytic defect and chronic low-back painJ G Previnaire, L Plaghki, C Col-de Beys, et al.
Thrombosis Research|November 1, 1996
Acquired activated protein C resistance in pregnancyA F Schlit, C Col-De Beys, M Moriau, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|December 1, 1986
The lupus anticoagulantM Moriau, E Lavenne-Pardonge, C Col-De Beys, et al.
Acta Chirurgica Belgica|March 1, 1986
[Treatment of the first episode of pulmonary embolism in the hospital. Anticoagulants, anti-platelet aggregation drugs and thrombolysis stimulants]M Moriau, E Lavenne-Pardonge, C Col-De Beys, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Thrombosis and Haemostasis|August 28, 1981
Effects of suloctidil on platelet survival time following cardiac valve replacementC Col-de Beys, A Ferrant, M Moriau
Thrombosis and Haemostasis|February 26, 1982
Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I.R.V.T.)M Moriau, C Col-De Beys, E Pardonge, et al.
Acta Belgica. Medica Physica : Organe Officiel De La Societe Royale Belge De Medecine Physique Et De Rehabilitation|October 1, 1990
Fibrinolytic defect and chronic low-back painJ G Previnaire, L Plaghki, C Col-de Beys, et al.
Thrombosis Research|November 1, 1996
Acquired activated protein C resistance in pregnancyA F Schlit, C Col-De Beys, M Moriau, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|December 1, 1986
The lupus anticoagulantM Moriau, E Lavenne-Pardonge, C Col-De Beys, et al.
Acta Chirurgica Belgica|March 1, 1986
[Treatment of the first episode of pulmonary embolism in the hospital. Anticoagulants, anti-platelet aggregation drugs and thrombolysis stimulants]M Moriau, E Lavenne-Pardonge, C Col-De Beys, et al.
Pageof 1